An ingestible capsule used to monitor gut health markers has taken another small step towards commercialisation, with RMIT University transferring IP ownership to Atmo Biosciences. Digital health business Atmo Biosciences is commercialising a capsule that it says “measures gases as it travels through the gastrointestinal tract and transmits the data wirelessly” and which was first…
The first Australian implant of a Total Artificial Heart (TAH) made by BiVACOR – founded by Australian inventor Dr Daniel Timms – was an “unmitigated clinical success”, according to the Artificial Heart Frontiers Program (AHFP.) The Artificial Heart Frontiers Program, led by Monash University, said on Wednesday that an unnamed Australian received the implant on…
Breakthrough Victoria has invested $800,000 in Diag-Nose.io Medical (DNM), a Melbourne-based innovator in respiratory healthcare, to enhance clinical management and drug discovery for chronic respiratory diseases globally. Originally launched from Stanford’s ENT Innovation Program and now headquartered in Notting Hill, Melbourne, Diag-Nose.io is revolutionising the treatment of chronic respiratory diseases (CRDs) like asthma and COPD,…
Radiopharmaceutical medical imaging manufacturer Cyclopharm has revealed a possible new use for its Technegas system – for evaluating the progress of lung transplantation. The use is detailed in a US-based study which highlights the clinical utility and operational benefits of the Technegas technology compared to current US ventilation imaging radiopharmaceuticals used in lung transplant evaluation.…
Drug manufacturer AstraZeneca has ordered four more APAS Independence laboratory instruments from AI microbiology automation manufacturer Clever Culture Systems, formally known as LBT Innovations. The order, worth $3.1 million over seven years, adds to the five APAS instruments already in use by the global pharmaceutical company, where they monitor for bacterial contamination in the company’s…
Radiopharmaceutical medical imaging company Cyclopharm has received its first purchase orders from two United States Veterans Health Administration (VA) Hospitals – part of the largest integrated US Government health care system in the United States (US). The purchase orders for an initial five-year term apply to the installation and annual charges associated with the Technegas…
Optiscan Imaging advances veterinary medtech Confocal microscopy manufacturer Optiscan Imaging has signed a Collaborative Research Agreement with the University of Minnesota College of Veterinary Medicine. The agreement follows a MOU with the university, and is a step in expanding the clinical applications of Optiscan’s confocal endomicroscope imaging system in veterinary medicine. The initial focus of…
ERA celebrates recycling of electronics In time for National Recycling Week Electrical Recycling Australia (ERA) has celebrated its achievements in recycling e-waste in South Australia. Backed by Bedford Industries, the company has in the the year to date notched up these statistics: 4,759 e-waste deliveries received; Daily average intake: 10,285 kilograms; and total e-waste processed:…
Rhythm receives R&D tax incentive refund Predictive cancer diagnostics technology company Rhythm Biosciences has received multiple tranches of its research and development tax incentive (RDTI), totalling $3.23 million. This total is made up of approximately $1.24 million in relation to FY23, being a second tranche of funds following the submission of an amended FY23 tax…
Brain imaging company EMVision Medical Devices has revealed what it called ‘exceptional’ results for its world-first emu scanner to identify stroke and stroke type. In total 307 participants were enrolled in the EMView trial and scanned with the EMVision emu brain scanner (pictured) at Liverpool Hospital, Royal Melbourne Hospital and the Princess Alexandra Hospital, including…
